NCT03780374

Brief Summary

A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired. These sound changing principles are enabled by respective hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono-centric at Sonova AG Headquarter based in Staefa.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

December 3, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 19, 2018

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2019

Completed
Last Updated

May 9, 2019

Status Verified

May 1, 2019

Enrollment Period

1 month

First QC Date

November 30, 2018

Last Update Submit

May 7, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Speech Intelligibility in Noise

    The speech intelligibility in noise with the three different sound processing principles will be assessed with the aid of the Oldenburg Sentence Test. The result will be shown in dB (decibel) SRT (Speech Reception Threshold).

    4 weeks

Secondary Outcomes (9)

  • Sound Quality - Overall

    16 weeks

  • Loudness - Laboratory

    8 weeks

  • Loudness - Daily Life

    16 weeks

  • Clarity - Daily Life

    16 weeks

  • Preferred Sound Processing Principle

    16 weeks

  • +4 more secondary outcomes

Study Arms (3)

Sound Processing Principle 1

ACTIVE COMPARATOR

Sound Processing Principle 1 will be applied in the hearing aid.

Device: Phonak Audéo L2M with Sound Processing Principle 1

Sound Processing Principle 2

EXPERIMENTAL

Sound Processing Principle 2 will be applied in the hearing aid.

Device: Phonak Audéo L2M with Sound Processing Principle 2

Sound Processing Principle 3

EXPERIMENTAL

Sound Processing Principle 3 will be applied in the hearing aid.

Device: Phonak Audéo L2M with Sound Processing Principle 3

Interventions

Compensation of a hearing loss with Sound Processing Principle 1.

Sound Processing Principle 1

Compensation of a hearing loss with Sound Processing Principle 2.

Sound Processing Principle 2

Compensation of a hearing loss with Sound Processing Principle 3.

Sound Processing Principle 3

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult hearing impaired persons (minimum age: 18 years) with and without experience with) hearing aids
  • Healthy outer ear (without previous surgical procedures)
  • Ability to fill in a questionnaire conscientiously
  • Informed Consent as documented by signature

You may not qualify if:

  • Contraindications to the medical device in this study, e.g. known hypersensitivity or allergy to the investigational product
  • Limited mobility and not in the position to attend weekly appointments
  • Limited ability to describe listening impressions/experiences and the use of the hearing aid
  • Inability to produce a reliable hearing test result
  • Massively limited dexterity
  • Known psychological problems
  • Known central hearing disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sonova AG

Stäfa, Canton of Zurich, 8712, Switzerland

Location

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participant's will not know which intervention will be applied.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each participant will be treated with sound principle 1, 2 and 3 in a crossover design.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2018

First Posted

December 19, 2018

Study Start

December 3, 2018

Primary Completion

January 15, 2019

Study Completion

March 15, 2019

Last Updated

May 9, 2019

Record last verified: 2019-05

Locations